References
Doube, A. Hepatitis and non-steroidal anti-inflammatory drugs. Ann Rheum Dis 1990, 49, 489–90.
Drew, R., Knights, K. Postulated reactive metabolites of NSAIDs. Agents Actions 1985, (Suppl. 17), 127–33.
Dunk, A.A., Walt, R.P., Jenkins, W.J., Sherlock, S.S. Diclofenac hepatitis. Br Med J 1982, 284, 1605–6.
Netter, P., Castut, A., Larvey, D., Carer, P., Banaworth, B., Trechot, P. Hepatitis induced by non-steroidal anti-inflammatory drugs. A co-operative study by French drug surveillance centres. Therapie 1988, 43, 229–33.
Andrejak, M., Davion, T., Gineston, J.L., Capron, J.P. Cross hepatotoxicity between non-steroidal anti-inflammatory drugs. Br Med J 1987, 295, 180–1.
Llorca, G., Lanbre, J.P., Collet, P.L., Ravault, A., Lejeune, E. Changing the class of NSAID in cases of hepatotoxicity. Ann Rheum Dis 1988, 47, 791.
Prescott, L.F. Effects of non-narcotic analgesics on the liver. Drugs 1986, 32, 129–147.
DeShayes, P., Le Loet, X., Bercoff, E., Fouin-Fortunet, H., Hepatite audiclofenac. Une Observation. Presse Med 1984, 13, 1847.
Ciccolunghi, S.N., Chaudri, H.A., Schubiger, B.I., Reddrop, R. Report on a long-term tolerability study of up to 2 years with diclofenac sodium (voltarol). Scand J Rheumatol 1978, 22, 86–96.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adebajo, A.O., Eastmond, C.J. Hepatotoxicity to several nonsteroidal anti-inflammatory drugs with diclofenac induced histological changes. Clin Rheumatol 11, 120–121 (1992). https://doi.org/10.1007/BF02207099
Issue Date:
DOI: https://doi.org/10.1007/BF02207099